Lupin Limited
LUPIN
Xếp hạng trong cổ phiếu
#2147
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Giá cổ phiếu
$20.35
Vốn hóa thị trường
$9.30B
Thay đổi (1 ngày)
-5.06%
Thay đổi (1 năm)
-7.79%
Quốc gia
IN
Giao dịch Lupin Limited (LUPIN)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Lupin Limited (LUPIN)
Giá đóng cửa cao nhất: $21.67 vào 2026-10-01
Giá đóng cửa thấp nhất: $0.15 vào 2001-09-01
Giá đóng cửa thấp nhất: $0.15 vào 2001-09-01
Lịch sử giá cổ phiếu của Lupin Limited từ 2001 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 4.87% |
| 2025 | -7.64% |
| 2024 | 65.92% |
| 2023 | 66.87% |
| 2022 | -23.57% |
| 2021 | -7.86% |
| 2020 | 20.18% |
| 2019 | -9.99% |
| 2018 | -9.76% |
| 2017 | -39.41% |
| 2016 | -19.49% |
| 2015 | 18.35% |
| 2014 | 59.89% |
| 2013 | 29.56% |
| 2012 | 32.51% |
| 2011 | -19.07% |
| 2010 | 66.57% |
| 2009 | 159.72% |
| 2008 | -20.92% |
| 2007 | 17.92% |
| 2006 | 53.29% |
| 2005 | 5.97% |
| 2004 | -2.10% |
| 2003 | 510.86% |
| 2002 | 19.06% |
| 2001 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
